Standard chemotherapy with or without bevacizumab in advanced ovarian cancer: quality-of-life outcomes from the International Collaboration on Ovarian Neoplasms (ICON7) phase 3 randomised trial

Dan Stark; Matthew Nankivell; Eric Pujade-lauraine; Gunnar Kristensen; Lorraine Elit; Martin Stockler; Felix Hilpert; Andrés Cervantes; Julia Brown; Anne Lanceley; Galina Velikova; Eduardo Sabate; Jacobus Pfisterer; Mark S Carey; Philip Beale; Wendi Qian; Ann Marie Swart; Amit Oza; Tim Perren

doi:10.1016/S1470-2045(12)70567-3

Standard chemotherapy with or without bevacizumab in advanced ovarian cancer: quality-of-life outcomes from the International Collaboration on Ovarian Neoplasms (ICON7) phase 3 randomised trial

Dan Stark, Matthew Nankivell, Eric Pujade-lauraine, Gunnar Kristensen, Lorraine Elit, Martin Stockler, Felix Hilpert, Andrés Cervantes, Julia Brown, Anne Lanceley, Galina Velikova, Eduardo Sabate, Jacobus Pfisterer, Mark S Carey, Philip Beale, Wendi Qian, Ann Marie Swart, Amit Oza, Tim Perren

Research output: Contribution to journal › Article › peer-review

122 Citations (Scopus)

Original language	English
Pages (from-to)	236-243
Journal	The Lancet Oncology
Volume	14
Issue number	3
DOIs	https://doi.org/10.1016/S1470-2045(12)70567-3
Publication status	Published - 1 Mar 2013

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/S1470-2045(12)70567-3

Cite this

Stark, D., Nankivell, M., Pujade-lauraine, E., Kristensen, G., Elit, L., Stockler, M., Hilpert, F., Cervantes, A., Brown, J., Lanceley, A., Velikova, G., Sabate, E., Pfisterer, J., Carey, M. S., Beale, P., Qian, W., Swart, A. M., Oza, A., & Perren, T. (2013). Standard chemotherapy with or without bevacizumab in advanced ovarian cancer: quality-of-life outcomes from the International Collaboration on Ovarian Neoplasms (ICON7) phase 3 randomised trial. The Lancet Oncology, 14(3), 236-243. https://doi.org/10.1016/S1470-2045(12)70567-3

@article{4860d9d74aca4de6910b373b9b1639f3,

title = "Standard chemotherapy with or without bevacizumab in advanced ovarian cancer: quality-of-life outcomes from the International Collaboration on Ovarian Neoplasms (ICON7) phase 3 randomised trial",

author = "Dan Stark and Matthew Nankivell and Eric Pujade-lauraine and Gunnar Kristensen and Lorraine Elit and Martin Stockler and Felix Hilpert and Andr{\'e}s Cervantes and Julia Brown and Anne Lanceley and Galina Velikova and Eduardo Sabate and Jacobus Pfisterer and Carey, {Mark S} and Philip Beale and Wendi Qian and Swart, {Ann Marie} and Amit Oza and Tim Perren",

year = "2013",

month = mar,

day = "1",

doi = "10.1016/S1470-2045(12)70567-3",

language = "English",

volume = "14",

pages = "236--243",

journal = "The Lancet Oncology",

issn = "1470-2045",

publisher = "Elsevier",

number = "3",

}

Stark, D, Nankivell, M, Pujade-lauraine, E, Kristensen, G, Elit, L, Stockler, M, Hilpert, F, Cervantes, A, Brown, J, Lanceley, A, Velikova, G, Sabate, E, Pfisterer, J, Carey, MS, Beale, P, Qian, W, Swart, AM, Oza, A & Perren, T 2013, 'Standard chemotherapy with or without bevacizumab in advanced ovarian cancer: quality-of-life outcomes from the International Collaboration on Ovarian Neoplasms (ICON7) phase 3 randomised trial', The Lancet Oncology, vol. 14, no. 3, pp. 236-243. https://doi.org/10.1016/S1470-2045(12)70567-3

Standard chemotherapy with or without bevacizumab in advanced ovarian cancer: quality-of-life outcomes from the International Collaboration on Ovarian Neoplasms (ICON7) phase 3 randomised trial. / Stark, Dan; Nankivell, Matthew; Pujade-lauraine, Eric et al.

In: The Lancet Oncology, Vol. 14, No. 3, 01.03.2013, p. 236-243.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Standard chemotherapy with or without bevacizumab in advanced ovarian cancer: quality-of-life outcomes from the International Collaboration on Ovarian Neoplasms (ICON7) phase 3 randomised trial

AU - Stark, Dan

AU - Nankivell, Matthew

AU - Pujade-lauraine, Eric

AU - Kristensen, Gunnar

AU - Elit, Lorraine

AU - Stockler, Martin

AU - Hilpert, Felix

AU - Cervantes, Andrés

AU - Brown, Julia

AU - Lanceley, Anne

AU - Velikova, Galina

AU - Sabate, Eduardo

AU - Pfisterer, Jacobus

AU - Carey, Mark S

AU - Beale, Philip

AU - Qian, Wendi

AU - Swart, Ann Marie

AU - Oza, Amit

AU - Perren, Tim

PY - 2013/3/1

Y1 - 2013/3/1

U2 - 10.1016/S1470-2045(12)70567-3

DO - 10.1016/S1470-2045(12)70567-3

M3 - Article

VL - 14

SP - 236

EP - 243

JO - The Lancet Oncology

JF - The Lancet Oncology

SN - 1470-2045

IS - 3

ER -